Richter's Syndrome: What It Is and How It Is Treated

Written by Medicover Team and Medically Reviewed by Dr Kovvuru Bhaskar Reddy , Oncologists

Causes
Find a Doctor
Diagnosis
Treatment
FAQs
Book an Appointment

1. Causes 2. Find a Doctor 3. Diagnosis 4. Treatment 5. FAQs

Richter's Syndrome, also called Richter transformation, is a rare and serious complication in which chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL) changes into a faster-growing type of lymphoma.

The most common form is diffuse large B-cell lymphoma (DLBCL). Less commonly, the transformation may resemble classical Hodgkin lymphoma. Richter's Syndrome usually progresses more rapidly than the original CLL or SLL and requires prompt evaluation and treatment.

What Are the Types of Richter's Syndrome?

Richter's Syndrome is classified according to the type of aggressive lymphoma that develops from or occurs in a person with CLL or SLL.

DLBCL-Type Richter's Syndrome: This is the most common form and involves transformation into diffuse large B-cell lymphoma, an aggressive non-Hodgkin lymphoma.
Hodgkin-Type Richter's Syndrome: This less common form has features of classical Hodgkin lymphoma and may require a different treatment approach.

What Are the Symptoms of Richter's Syndrome?

Richter's Syndrome often causes a sudden change in symptoms in a person with previously stable or slowly progressing CLL or SLL. Symptoms may develop rapidly and can resemble those of other aggressive lymphomas.

Rapidly Enlarging Lymph Nodes: One or more lymph nodes may suddenly increase in size and become painful or uncomfortable.
Fever: Persistent or unexplained fever may occur without an obvious infection.
Night Sweats: Drenching night sweats may become more frequent or severe.
Unexplained Weight Loss: Significant unintentional weight loss can be a sign of aggressive lymphoma.
Fatigue and Weakness: Severe fatigue may interfere with normal daily activities.
Abdominal Discomfort: Enlargement of the spleen or liver may cause abdominal pain, fullness or discomfort.
Declining General Health: A sudden deterioration in overall well-being may indicate disease transformation.

What Causes Richter's Syndrome?

The exact cause of Richter's Syndrome is not fully understood. It develops when CLL or SLL cells acquire additional biological and genetic changes that allow them to grow more rapidly and behave like an aggressive lymphoma.

Genetic Changes: Alterations involving genes such as TP53, NOTCH1, CDKN2A and MYC are associated with an increased risk of transformation.
CLL Cell Evolution: Additional changes may accumulate in CLL cells over time, allowing a more aggressive lymphoma to develop.
Immune System Dysfunction: Immune abnormalities associated with CLL may reduce the body's ability to control abnormal lymphocyte growth.
Clonally Related Disease: In many cases, the aggressive lymphoma develops from the same abnormal cell population as the original CLL.
Clonally Unrelated Disease: Less commonly, the aggressive lymphoma develops as a separate cancer that is biologically unrelated to the original CLL.

When to See a Doctor for Richter's Syndrome?

Medical evaluation by an oncologist is recommended when a person with CLL or SLL develops rapidly enlarging lymph nodes, persistent fever, drenching night sweats, unexplained weight loss, or a sudden decline in health. These changes may require prompt testing for Richter transformation.

You should see a doctor if you have:

A lymph node that suddenly increases in size
Persistent fever, night sweats or unexplained weight loss
Increasing fatigue, weakness or abdominal discomfort

Get medical help immediately if:

Severe breathing or swallowing difficulty develops
There is sudden severe weakness, confusion or loss of consciousness
High fever occurs with signs of a serious infection

These could be signs of a serious complication like aggressive lymphoma, which needs urgent care.

Find Oncologists for Richters Syndrome Treatment Near You

How Is Richter's Syndrome Diagnosed?

Diagnosing Richter's Syndrome requires a combination of clinical evaluation, blood tests, imaging and tissue biopsy. A biopsy is essential because symptoms and imaging findings alone cannot reliably confirm the transformation.

Clinical Evaluation

A healthcare provider reviews changes in symptoms, the history of CLL or SLL and the presence of rapidly enlarging lymph nodes, spleen enlargement or other signs of aggressive disease.

Blood Tests

Blood tests may include a complete blood count, liver and kidney function tests and lactate dehydrogenase (LDH) measurement. A markedly elevated LDH level may raise suspicion of aggressive lymphoma but does not confirm the diagnosis.

PET-CT Scan

A PET-CT scan can identify areas with increased metabolic activity and help select the most appropriate lymph node or tissue for biopsy.

Biopsy

A tissue biopsy is required to confirm Richter's Syndrome. Whenever possible, an excisional or core needle biopsy of the most suspicious area is performed to determine the lymphoma type.

Genetic and Molecular Testing

Additional testing may identify genetic changes, determine whether the transformed lymphoma is related to the original CLL and provide information that may help guide treatment.

Bone Marrow Examination

A bone marrow biopsy may be performed in selected cases to assess the extent of disease and support treatment planning.

How Is Richter's Syndrome Treated?

Treatment for Richter's Syndrome depends on the lymphoma type, previous CLL treatments, genetic features, overall health and whether the transformed disease is newly diagnosed or has returned. Care is usually provided by a haematologist or medical oncologist experienced in aggressive lymphomas.

Combination Chemoimmunotherapy

Combination regimens may be used to treat DLBCL-type Richter's Syndrome.
R-CHOP or other intensive lymphoma-based regimens may be considered depending on individual disease characteristics.
Treatment choice is influenced by previous therapies, genetic findings and overall fitness.

Targeted Therapy

Targeted medicines may be used alone or in combination with other treatments in selected patients.
Therapies directed at specific lymphoma pathways are being increasingly studied for Richter's Syndrome.
The choice of treatment depends on previous CLL therapy and the biological features of the transformed lymphoma.

Immunotherapy

Immune-based treatments may be considered for selected patients with relapsed or treatment-resistant disease.
CAR T-cell therapy may be an option at specialised centres for some eligible patients.
Other antibody-based and cellular therapies may be available through specialist programmes or clinical trials.

Stem Cell Transplantation

Allogeneic stem cell transplantation may be considered for selected medically fit patients who respond well to initial treatment.
The decision depends on age, overall health, treatment response and availability of a suitable donor.

Treatment for Hodgkin-Type Richter's Syndrome

Hodgkin-type transformation is generally treated with regimens used for classical Hodgkin lymphoma.
The treatment plan is individualised according to disease extent, previous therapy and overall health.

Clinical Trials

Clinical trials are important because Richter's Syndrome is rare and standard treatment outcomes remain limited.
Trials may provide access to new targeted therapies, immunotherapies and treatment combinations.

Your health is everything - prioritize your well-being today.

Consult Richters Syndrome Doctors Today

What Are the Risk Factors for Richter's Syndrome?

Only a minority of people with CLL or SLL develop Richter's Syndrome. Certain clinical, genetic and molecular features are associated with a higher risk of transformation.

High-Risk Genetic Changes: Abnormalities involving TP53, NOTCH1 and other genes may increase the risk.
Unmutated IGHV: Certain CLL biological features, including unmutated IGHV status, are associated with a higher risk.
Advanced or Aggressive CLL: More active or difficult-to-control disease may be associated with transformation.
Bulky Lymph Nodes: Large lymph nodes or rapidly increasing disease burden may be linked to a greater risk.
Previous CLL Treatment: Richter's Syndrome can occur in both treated and untreated patients, although treatment history may influence risk and treatment options.

What Are the Complications of Richter's Syndrome?

Richter's Syndrome can progress quickly and affect lymph nodes, bone marrow and organs outside the lymphatic system. Complications depend on the location and extent of the transformed lymphoma.

Rapid enlargement of lymph nodes
Bone marrow failure and low blood cell counts
Severe or recurrent infections
Enlargement of the spleen or liver
Organ dysfunction caused by lymphoma involvement
Treatment-related complications
Relapsed or treatment-resistant lymphoma

What Is the Prognosis for Richter's Syndrome?

The prognosis of Richter's Syndrome varies between individuals and is generally less favourable than that of CLL alone. Outcomes depend on the type of transformation, genetic features, previous treatments, overall health and response to therapy.

Clonal Relationship: Lymphoma that is unrelated to the original CLL may have a better outlook than clonally related transformation.
Genetic Features: Certain high-risk genetic abnormalities may be associated with more difficult-to-treat disease.
Treatment Response: People who achieve a strong response to initial therapy may have better outcomes.
Overall Health: Age, fitness and other medical conditions can influence treatment choices and prognosis.

How Is Richter's Syndrome Managed?

Ongoing management focuses on controlling the lymphoma, monitoring treatment response, preventing complications and supporting physical and emotional well-being.

Regular Monitoring

Blood tests and imaging may be used to assess treatment response.
New or worsening symptoms should be reported promptly.

Infection Prevention

People with Richter's Syndrome may have weakened immunity because of the disease and its treatment.
Healthcare providers may recommend preventive medicines, vaccinations or other measures based on individual risk.

Nutritional and Symptom Support

Nutritional support may help people experiencing weight loss or reduced appetite.
Pain, fatigue, fever and other symptoms should be actively managed during treatment.